{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:44:31Z","timestamp":1764175471672},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s10552-023-01803-x","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T11:02:17Z","timestamp":1697713337000},"page":"477-486","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Potential beneficial effects of long-term aspirin use on the prevalence of colorectal cancer: a population-based study of the US Nationwide Inpatient Sample"],"prefix":"10.1007","volume":"35","author":[{"given":"Ko-Chao","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan-Chih","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Hwa","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kung-Chuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuen-Lin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Chiao","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"key":"1803_CR1","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB (2019) Colorectal cancer. Lancet 394:1467\u20131480","journal-title":"Lancet"},{"key":"1803_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3322\/caac.21601","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Goding Sauer A et al (2020) Colorectal cancer statistics, 2020. CA Cancer J Clin 70:145\u2013164","journal-title":"CA Cancer J Clin"},{"key":"1803_CR3","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","volume":"66","author":"M Arnold","year":"2017","unstructured":"Arnold M, Sierra MS, Laversanne M et al (2017) Global patterns and trends in colorectal cancer incidence and mortality. Gut 66:683\u2013691","journal-title":"Gut"},{"key":"1803_CR4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424","journal-title":"CA Cancer J Clin"},{"key":"1803_CR5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.bpg.2011.10.015","volume":"25","author":"X Garcia-Albeniz","year":"2011","unstructured":"Garcia-Albeniz X, Chan AT (2011) Aspirin for the prevention of colorectal cancer. Best Pract Res Clin Gastroenterol 25:461\u2013472","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1803_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/ijms18010197","volume":"18","author":"I M\u00e1rmol","year":"2017","unstructured":"M\u00e1rmol I, S\u00e1nchez-de-Diego C, Pradilla Dieste A, Cerrada E, Rodriguez Yoldi MJ (2017) Colorectal carcinoma: a general overview and future perspectives in colorectal cancer. Int J Mol Sci 18:197","journal-title":"Int J Mol Sci"},{"key":"1803_CR7","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1001\/jama.2008.839","volume":"300","author":"E Botteri","year":"2008","unstructured":"Botteri E, Iodice S, Bagnardi V et al (2008) Smoking and colorectal cancer: a meta-analysis. JAMA 300:2765\u20132778","journal-title":"JAMA"},{"key":"1803_CR8","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/CEJ.0000000000000076","volume":"23","author":"S Cai","year":"2014","unstructured":"Cai S, Li Y, Ding Y, Chen K, Jin M (2014) Alcohol drinking and the risk of colorectal cancer death: a meta-analysis. Eur J Cancer Prev 23:532\u2013539","journal-title":"Eur J Cancer Prev"},{"key":"1803_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j477","volume":"356","author":"M Kyrgiou","year":"2017","unstructured":"Kyrgiou M, Kalliala I, Markozannes G et al (2017) Adiposity and cancer at major anatomical sites: umbrella review of the literature. BMJ 356:j477","journal-title":"BMJ"},{"key":"1803_CR10","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.3748\/wjg.v25.i30.4148","volume":"25","author":"WT Clarke","year":"2019","unstructured":"Clarke WT, Feuerstein JD (2019) Colorectal cancer surveillance in inflammatory bowel disease: practice guidelines and recent developments. World J Gastroenterol 25:4148\u20134157","journal-title":"World J Gastroenterol"},{"key":"1803_CR11","doi-asserted-by":"publisher","first-page":"967","DOI":"10.2147\/CIA.S109285","volume":"11","author":"K Simon","year":"2016","unstructured":"Simon K (2016) Colorectal cancer development and advances in screening. Clin Interv Aging 11:967\u2013976","journal-title":"Clin Interv Aging"},{"key":"1803_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12902-019-0444-6","volume":"19","author":"G Soltani","year":"2019","unstructured":"Soltani G, Poursheikhani A, Yassi M et al (2019) Obesity, diabetes and the risk of colorectal adenoma and cancer. BMC Endocr Disord 19:113","journal-title":"BMC Endocr Disord"},{"key":"1803_CR13","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3748\/wjg.v22.i3.933","volume":"22","author":"S Meeker","year":"2016","unstructured":"Meeker S, Seamons A, Maggio-Price L, Paik J (2016) Protective links between vitamin D, inflammatory bowel disease and colon cancer. World J Gastroenterol 22:933\u2013948","journal-title":"World J Gastroenterol"},{"key":"1803_CR14","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1042\/BST20140322","volume":"43","author":"M Dovizio","year":"2015","unstructured":"Dovizio M, Alberti S, Sacco A et al (2015) Novel insights into the regulation of cyclooxygenase-2 expression by platelet-cancer cell cross-talk. Biochem Soc Trans 43:707\u2013714","journal-title":"Biochem Soc Trans"},{"issue":"Suppl","key":"1803_CR15","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1194\/jlr.R800042-JLR200","volume":"50","author":"CA Rouzer","year":"2009","unstructured":"Rouzer CA, Marnett LJ (2009) Cyclooxygenases: structural and functional insights. J Lipid Res 50(Suppl):S29-34","journal-title":"J Lipid Res"},{"key":"1803_CR16","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","volume":"31","author":"E Ricciotti","year":"2011","unstructured":"Ricciotti E, FitzGerald GA (2011) Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol 31:986\u20131000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1803_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8295054","author":"R Bauersachs","year":"2019","unstructured":"Bauersachs R, Zeymer U, Bri\u00e8re JB et al (2019) Burden of coronary artery disease and peripheral artery disease: a literature review. Cardiovasc Ther. https:\/\/doi.org\/10.1155\/2019\/8295054","journal-title":"Cardiovasc Ther"},{"key":"1803_CR18","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.2174\/138161212803251943","volume":"18","author":"R De Caterina","year":"2012","unstructured":"De Caterina R, Renda G (2012) Clinical use of aspirin in ischemic heart disease: past, present and future. Curr Pharm Des 18:5215\u20135223","journal-title":"Curr Pharm Des"},{"key":"1803_CR19","first-page":"146","volume":"68","author":"DK Smith","year":"2019","unstructured":"Smith DK, Demetriou T, Weber C (2019) Aspirin for primary prevention: USPSTF recommendations for CVD and colorectal cancer. J Fam Pract 68:146\u2013151","journal-title":"J Fam Pract"},{"key":"1803_CR20","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ijcard.2017.08.013","volume":"248","author":"F Andreotti","year":"2017","unstructured":"Andreotti F, De Caterina R, Crea F (2017) Aspirin and the prevention of a common disease: colorectal cancer. Int J Cardiol 248:394\u2013395","journal-title":"Int J Cardiol"},{"key":"1803_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nrc.2016.4","volume":"16","author":"DA Drew","year":"2016","unstructured":"Drew DA, Cao Y, Chan AT (2016) Aspirin and colorectal cancer: the promise of precision chemoprevention. Nat Rev Cancer 16:173\u2013186","journal-title":"Nat Rev Cancer"},{"key":"1803_CR22","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1016\/j.cgh.2018.12.012","volume":"17","author":"A Rodr\u00edguez-Miguel","year":"2019","unstructured":"Rodr\u00edguez-Miguel A, Garc\u00eda-Rodr\u00edguez LA, Gil M et al (2019) Clopidogrel and low-dose aspirin, alone or together, reduce risk of colorectal cancer. Clin Gastroenterol Hepatol 17:2024-2033.e2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1803_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.critrevonc.2016.05.011","volume":"104","author":"G Singh Ranger","year":"2016","unstructured":"Singh Ranger G (2016) The role of aspirin in colorectal cancer chemoprevention. Crit Rev Oncol Hematol 104:87\u201390","journal-title":"Crit Rev Oncol Hematol"},{"key":"1803_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/ijc.28634","volume":"135","author":"LM Hollestein","year":"2014","unstructured":"Hollestein LM, van Herk-Sukel MP, Ruiter R et al (2014) Incident cancer risk after the start of aspirin use: results from a Dutch population-based cohort study of low dose aspirin users. Int J Cancer 135:157\u2013165","journal-title":"Int J Cancer"},{"key":"1803_CR25","first-page":"13435","volume":"8","author":"B Kim","year":"2015","unstructured":"Kim B, Park SJ, Hong SP et al (2015) The effect of prediagnostic aspirin use on the prognosis of stage III colorectal cancer. Int J Clin Exp Med 8:13435\u201313445","journal-title":"Int J Clin Exp Med"},{"issue":"2","key":"1803_CR26","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3171\/2015.12.JNS151107","volume":"126","author":"HH Dasenbrock","year":"2017","unstructured":"Dasenbrock HH, Yan SC, Gross BA et al (2017) The impact of aspirin and anticoagulant usage on outcomes after aneurysmal subarachnoid hemorrhage: a Nationwide Inpatient Sample analysis. J Neurosurg 126(2):537\u2013547","journal-title":"J Neurosurg"},{"issue":"7","key":"1803_CR27","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1097\/MEG.0000000000002578","volume":"35","author":"H Chaudhry","year":"2023","unstructured":"Chaudhry H, Sohal A, Dukovic D et al (2023) Does use of long-term aspirin impact outcomes in patients with acute pancreatitis? Eur J Gastroenterol Hepatol 35(7):721\u2013727","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"1803_CR28","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1177\/1074248420925021","volume":"25","author":"P Li","year":"2020","unstructured":"Li P, Ning Y, Li M et al (2020) Aspirin is associated with reduced rates of venous thromboembolism in older patients with cancer. J Cardiovasc Pharmacol Ther 25(5):456\u2013465","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"1803_CR29","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2174\/1381612043453144","volume":"10","author":"FA Fitzpatrick","year":"2004","unstructured":"Fitzpatrick FA (2004) Cyclooxygenase enzymes: regulation and function. Curr Pharm Des 10:577\u2013588","journal-title":"Curr Pharm Des"},{"key":"1803_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21239018","author":"R Sankaranarayanan","year":"2020","unstructured":"Sankaranarayanan R, Kumar DR, Altinoz MA, Bhat GJ (2020) Mechanisms of colorectal cancer prevention by aspirin-A literature review and perspective on the role of COX-dependent and -independent pathways. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21239018","journal-title":"Int J Mol Sci"},{"key":"1803_CR31","doi-asserted-by":"publisher","first-page":"17597","DOI":"10.1073\/pnas.1209192109","volume":"109","author":"NS Kirkby","year":"2012","unstructured":"Kirkby NS, Lundberg MH, Harrington LS et al (2012) Cyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular system. Proc Natl Acad Sci U S A 109:17597\u201317602","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1803_CR32","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1111\/bcp.13048","volume":"82","author":"C Patrono","year":"2016","unstructured":"Patrono C (2016) Cardiovascular effects of cyclooxygenase-2 inhibitors: a mechanistic and clinical perspective. Br J Clin Pharmacol 82:957\u2013964","journal-title":"Br J Clin Pharmacol"},{"key":"1803_CR33","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1124\/pr.56.3.3","volume":"56","author":"DL Simmons","year":"2004","unstructured":"Simmons DL, Botting RM, Hla T (2004) Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56:387\u2013437","journal-title":"Pharmacol Rev"},{"issue":"Suppl 1","key":"1803_CR34","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1046\/j.1365-2036.2000.014s1064.x","volume":"14","author":"RN Dubois","year":"2000","unstructured":"Dubois RN (2000) Review article: cyclooxygenase\u2013a target for colon cancer prevention. Aliment Pharmacol Ther 14(Suppl 1):64\u201367","journal-title":"Aliment Pharmacol Ther"},{"key":"1803_CR35","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1161\/CIRCRESAHA.109.204529","volume":"106","author":"Y Yu","year":"2010","unstructured":"Yu Y, Stubbe J, Ibrahim S et al (2010) Cyclooxygenase-2-dependent prostacyclin formation and blood pressure homeostasis: targeted exchange of cyclooxygenase isoforms in mice. Circ Res 106:337\u2013345","journal-title":"Circ Res"},{"key":"1803_CR36","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1021\/acs.analchem.7b05337","volume":"90","author":"B Gurram","year":"2018","unstructured":"Gurram B, Zhang S, Li M et al (2018) Celecoxib conjugated fluorescent probe for identification and discrimination of cyclooxygenase-2 enzyme in cancer cells. Anal Chem 90:5187\u20135193","journal-title":"Anal Chem"},{"key":"1803_CR37","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1080\/00365520121464","volume":"36","author":"BP van Rees","year":"2001","unstructured":"van Rees BP, Ristim\u00e4ki A (2001) Cyclooxygenase-2 in carcinogenesis of the gastrointestinal tract. Scand J Gastroenterol 36:897\u2013903","journal-title":"Scand J Gastroenterol"},{"key":"1803_CR38","first-page":"3785","volume":"55","author":"H Sano","year":"1995","unstructured":"Sano H, Kawahito Y, Wilder RL et al (1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 55:3785\u20133789","journal-title":"Cancer Res"},{"key":"1803_CR39","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.31557\/APJCP.2019.20.6.1675","volume":"20","author":"RR Negi","year":"2019","unstructured":"Negi RR, Rana SV, Gupta V et al (2019) Over-expression of cyclooxygenase-2 in colorectal cancer patients. Asian Pac J Cancer Prev 20:1675\u20131681","journal-title":"Asian Pac J Cancer Prev"},{"key":"1803_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-230X-14-1","volume":"14","author":"HM Roelofs","year":"2014","unstructured":"Roelofs HM, Te Morsche RH, van Heumen BW, Nagengast FM, Peters WH (2014) Over-expression of COX-2 mRNA in colorectal cancer. BMC Gastroenterol 14:1","journal-title":"BMC Gastroenterol"},{"key":"1803_CR41","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1016\/S0140-6736(19)30541-0","volume":"393","author":"I Raber","year":"2019","unstructured":"Raber I, McCarthy CP, Vaduganathan M et al (2019) The rise and fall of aspirin in the primary prevention of cardiovascular disease. Lancet 393:2155\u20132167","journal-title":"Lancet"},{"key":"1803_CR42","doi-asserted-by":"publisher","first-page":"AP078","DOI":"10.1161\/circ.143.suppl_1.P078","volume":"143","author":"O Dasa","year":"2021","unstructured":"Dasa O, Jun I, Sajdeya R et al (2021) Gender and racial disparities in aspirin use for primary prevention: temporal trends from the national health and nutrition examination surveys, 2011\u20132018. Circulation 143:AP078","journal-title":"Circulation"},{"key":"1803_CR43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1741-7015-5-29","volume":"5","author":"T Yerman","year":"2007","unstructured":"Yerman T, Gan WQ, Sin DD (2007) The influence of gender on the effects of aspirin in preventing myocardial infarction. BMC Med 5:29","journal-title":"BMC Med"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-023-01803-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-023-01803-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-023-01803-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T07:15:38Z","timestamp":1707030938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-023-01803-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,19]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["1803"],"URL":"https:\/\/doi.org\/10.1007\/s10552-023-01803-x","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,19]]},"assertion":[{"value":"24 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was submitted to the Institutional Review Board (IRB) of Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, and the study was granted an exemption from IRB approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animals participants"}},{"value":"Due to the fact that all data in the NIS database is de-identified, informed consent was not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}